Raimar Löbenberg

8.9k total citations · 2 hit papers
197 papers, 6.8k citations indexed

About

Raimar Löbenberg is a scholar working on Pharmaceutical Science, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Raimar Löbenberg has authored 197 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Pharmaceutical Science, 40 papers in Molecular Biology and 29 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Raimar Löbenberg's work include Drug Solubulity and Delivery Systems (59 papers), Advanced Drug Delivery Systems (31 papers) and Inhalation and Respiratory Drug Delivery (23 papers). Raimar Löbenberg is often cited by papers focused on Drug Solubulity and Delivery Systems (59 papers), Advanced Drug Delivery Systems (31 papers) and Inhalation and Respiratory Drug Delivery (23 papers). Raimar Löbenberg collaborates with scholars based in Canada, Brazil and United States. Raimar Löbenberg's co-authors include Wilson Roa, Shirzad Azarmi, Nádia Araci Bou‐Chacra, Jennifer Dressman, Christos Reppas, Eric Galia, Eleftheria Nicolaides, Warren H. Finlay, Hai Wei and J. Kreuter and has published in prestigious journals such as SHILAP Revista de lepidopterología, Applied Physics Letters and Advanced Drug Delivery Reviews.

In The Last Decade

Raimar Löbenberg

189 papers receiving 6.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evaluation of Various Dissolution Media for Predicting In Vivo Performance of Class I and II Drugs

1998 770 citations Raimar Löbenberg et al. profile →
Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards

2000 571 citations Raimar Löbenberg profile →

Peers

Countries citing papers authored by Raimar Löbenberg

Since Specialization

Citations

This map shows the geographic impact of Raimar Löbenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raimar Löbenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raimar Löbenberg more than expected).

Fields of papers citing papers by Raimar Löbenberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raimar Löbenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raimar Löbenberg. The network helps show where Raimar Löbenberg may publish in the future.

Co-authorship network of co-authors of Raimar Löbenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Raimar Löbenberg. A scholar is included among the top collaborators of Raimar Löbenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raimar Löbenberg. Raimar Löbenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development of a Physiologically Relevant Simulated Nasal Fluid for In Vitro Dissolution Studies 2025 ·Dissolution Technologies ·(unknown), (unknown), Neal M. Davies, Raimar Löbenberg	4
2	Pharmacokinetics of Psilocybin: A Systematic Review 2025 ·Pharmaceutics ·Shakila Meshkat, (unknown), (unknown), (unknown), Richard J. Zeifman, Yanbo Zhang, Lisa Burback, (unknown), Andrew J. Greenshaw, Muhammad Ishrat Husain, Amy C. Reichelt, Eric Vermetten, Manish K. Jha, Rakesh Jetly, Raimar Löbenberg, Venkat Bhat	0
3	Oleosome Delivery Systems: Enhancing Stability and Therapeutic Potential of Natural Products and Xenobiotics 2025 ·Pharmaceutics ·(unknown), (unknown), Sheng Zhao, Maryam Salami, Raimar Löbenberg, Neal M. Davies	0
4	Fabrication and Characterization of Curcumin-Complexed Nanoparticles Using Coconut Protein Nanoparticles 2025 ·Pharmaceutics ·(unknown), Maryam Salami, Gholam Reza Askari, Zahra Emam‐Djomeh, Raimar Löbenberg, Michael J. Serpe, Neal M. Davies	0
5	Improved transdermal delivery of novel cannabinoid-loaded patches using Eudragit matrix 2024 ·Journal of Drug Delivery Science and Technology ·(unknown), Kornkanok Ingkaninan, Neti Waranuch, Chulhun Park, (unknown), (unknown), Raimar Löbenberg	2
6	Assessing the utility of in silico tools in early drug development: The case of a pharmaceutically relevant formulation of the prodrug psilocybin 2024 ·Journal of Drug Delivery Science and Technology ·(unknown), Jozef Al-Gousous, Gabriel Lima Barros de Araújo, Neal M. Davies, Raimar Löbenberg	2
7	A review on lipid and polymeric nano-based 17-β-estradiol delivery systems: advances and challenges 2024 ·Journal of Pharmacy & Pharmaceutical Sciences ·(unknown), (unknown), (unknown), Cristiano de Jesus Correia, Luíz Felipe Pinho Moreira, Raimar Löbenberg, Ana Cristina Breithaupt‐Faloppa, Nádia Araci Bou‐Chacra	1
8	Hydroxymethylnitrofurazone Lymphatic Uptake with Nanostructured Lipid Carrier After Oral Administration in Rats 2024 ·Nanomedicine ·(unknown), Cauê Benito Scarim, Paulo C. Cotrim, Fernando Barbosa, Bruno Alves Rocha, (unknown), Cristiano de Jesus Correia, Gabriel Lima Barros de Araújo, Raimar Löbenberg, Nádia Araci Bou‐Chacra, Ana Cristina Breithaupt‐Faloppa	2
9	A validated method for detection of cannflavins in hemp extracts 2023 ·Journal of Pharmaceutical and Biomedical Analysis ·(unknown), (unknown), Michael R. Doschak, Raimar Löbenberg, Neal M. Davies	4
10	Unveiling microtubule dynamics in lung cancer: Recent findings and prospects for drug delivery and treatment 2023 ·Journal of Drug Delivery Science and Technology ·Megumi Nishitani Yukuyama, (unknown), (unknown), Gabriel Lima Barros de Araújo, Raimar Löbenberg, (unknown), (unknown), (unknown), Claudiana Lameu, (unknown), (unknown), (unknown), (unknown), Nádia Araci Bou‐Chacra	2
11	Using GastroPlus to teach complex biopharmaceutical concepts 2022 ·Pharmacy Education ·(unknown), (unknown), (unknown), Neal M. Davies, Raimar Löbenberg	3
12	Investigations of the antipyretic effect and safety of Prasachandaeng, a traditional remedy from Thailand national list of essential medicines 2022 ·Biomedicine & Pharmacotherapy ·(unknown), Arunporn Itharat, (unknown), (unknown), (unknown), Adis Tasanarong, Raimar Löbenberg, (unknown), Neal M. Davies, B. Ooraikul	5
13	Bortezomib-loaded lipidic-nano drug delivery systems; formulation, therapeutic efficacy, and pharmacokinetics 2021 ·Journal of Microencapsulation ·Mohammad Mahmoudian, Hadi Valizadeh, Raimar Löbenberg, Parvin Zakeri‐Milani	12
14	Oral delivery of solid lipid nanoparticles: underlining the physicochemical characteristics and physiological condition affecting the lipolysis rate 2021 ·Expert Opinion on Drug Delivery ·Mohammad Mahmoudian, Solmaz Maleki Dizaj, Sara Salatin, Raimar Löbenberg, Maryam Saadat, Ziba Islambulchilar, Hadi Valizadeh, Parvin Zakeri‐Milani	14
15	Enhancement of the intestinal absorption of bortezomib by self-nanoemulsifying drug delivery system 2019 ·Pharmaceutical Development and Technology ·Mohammad Mahmoudian, Hadi Valizadeh, Raimar Löbenberg, Parvin Zakeri‐Milani	13
16	Development of an algorithm to identify mass production candidate molecules to develop children’s oral medicines: a North American perspective 2016 ·SHILAP Revista de lepidopterología ·Varsha Bhatt‐Mehta, Robert B. MacArthur, Raimar Löbenberg, Jeffrey J. Cies, (unknown), Richard H. Parrish	3
17	Toward Global Standards for Comparator Pharmaceutical Products: Case Studies of Amoxicillin, Metronidazole, and Zidovudine in the Americas 2012 ·The AAPS Journal ·Raimar Löbenberg, Nádia Araci Bou‐Chacra, Erika Stippler, Vinod P. Shah, Anthony J. DeStefano, Walter W. Hauck, Roger Williams	28
18	Investigation of vitamin and mineral tablets and capsules on the Canadian market. 2006 ·PubMed ·Raimar Löbenberg, (unknown)	9
19	Body distribution of azidothymidine bound to hexyl-cyanoacrylate nanoparticles after i.v. injection to rats 1998 ·Journal of Controlled Release ·Raimar Löbenberg	86
20	Macrophage Targeting of Azidothymidine: A Promising Strategy for AIDS Therapy* 1996 ·AIDS Research and Human Retroviruses ·Raimar Löbenberg, Jörg Kreuter	55

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact